We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Why Does Ketamine Fight Depression? Finding Answers at BNA 2019

A significant minority of major depressive disorder patients don’t respond to currently available antidepressant medication. A newly approved treatment, based on the "club drug" ketamine, could change that. In a session at the British Neuroscience Association’s Festival of Neuroscience 2019, the potential mechanisms of ketamine’s antidepressant action were put under examination.

Read More

Chatting Cannabis With Amanda Feilding, the Countess of Psychedelic Science

Analytical Cannabis speaks to the Queen of Consciousness herself about cannabis, campaigning, and creating a leading foundation for drug science and research.

Read More

Microdosers of LSD and Magic Mushrooms are Wiser and More Creative

Researchers just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.

Read More

Exploring Consciousness with Psychedelics

Chris Timmermann, from The Psychedelic Research group at Imperial College London studies the action of psychedelics on the brain and their potential as therapeutics. This article reviews their research and their implications.

Read More

 
Advertisement